lymphoma

ESMO18: Merck’s STING agonist lacks bite on its own
ESMO18: Merck’s STING agonist lacks bite on its own
Fierce Biotech
Merck
STING agonists
MK-1454
Keytruda
solid tumors
lymphoma
Flag link:
AbbVie's stock falls after lymphoma treatment trial data disappoints
AbbVie's stock falls after lymphoma treatment trial data disappoints
Marketwatch
AbbVie
ibrutinib
clinical trials
lymphoma
Flag link:
Common Serious Side-Effect Of CAR T-Cell Therapy May Be Preventable
Common Serious Side-Effect Of CAR T-Cell Therapy May Be Preventable
Forbes
CAR-T
CRS
lymphoma
leukemia
cytokine release syndrome
Flag link:
Hemo-oncology newbie Bayer gears up for copanlisib launch
Hemo-oncology newbie Bayer gears up for copanlisib launch
Fierce Pharma
hemo-oncology
Bayer
drug launches
copanlisib
lymphoma
Flag link:
Two cancer drug prices have already been hiked by 8% this year
Two cancer drug prices have already been hiked by 8% this year
Marketwatch
drug pricing
cancer
Amgen
Blincyto
Teva Pharmaceutical
Treanda
lymphoma
leukemia
Flag link:
Novartis backs Gamida Cell’s $40M raise to fund a looming PhIII study, marketing and manufacturing prep
Novartis backs Gamida Cell’s $40M raise to fund a looming PhIII study, marketing and manufacturing prep
Endpoints
Novartis
Gamida Cell
clinical trials
cell grafts
bone marrow
leukemia
lymphoma
Flag link:
Novartis' CAR-T stacks up to Kite in lymphoma
Novartis' CAR-T stacks up to Kite in lymphoma
BioPharma Dive
Novartis
CAR-T
Kite Pharma
CTL019
axi-cel
lymphoma
Flag link:
Celldex Cancer Drug Shows Good Early Data
Celldex Cancer Drug Shows Good Early Data
Investopedia
Celldex Therapeutics
CDX-1140
lymphoma
Flag link:
Seattle Genetics moves up FDA timeline for cash cow drug Adcetris
Seattle Genetics moves up FDA timeline for cash cow drug Adcetris
Bizjournals.com
Seattle Genetics
FDA
Adcetris
lymphoma
Flag link:
Glimpse of promising lymphoma responses spurs a sharp spike in Epizyme shares
Glimpse of promising lymphoma responses spurs a sharp spike in Epizyme shares
Fierce Biotech
lymphoma
EPZ-6438
Epizyme
Flag link:
JNJ launches PhII lymphoma study for daratumumab
JNJ launches PhII lymphoma study for daratumumab
Fierce Biotech
JNJ
lymphoma
daratumumab
Genmab
non-Hodgkin's lymphoma
Flag link:
US FDA grants fast tract status to MorphoSys's MOR208 programme to treat DLBCL
US FDA grants fast tract status to MorphoSys's MOR208 programme to treat DLBCL
PharmaBiz
diffuse large B-cell lymphoma
lymphoma
MorphoSys
MOR208
Flag link:
Data on Celgene's Revlimid Published in Oncology Journal
Data on Celgene's Revlimid Published in Oncology Journal
Yahoo/Zacks
Celgene
Revlimid
diffuse large B-cell lymphoma
lymphoma
Flag link:
ProNAi nabs $59.5M round to back PhII lymphoma drug
ProNAi nabs $59.5M round to back PhII lymphoma drug
Fierce Biotech
ProNai
PNT2258
lymphoma
Flag link:
Infinity Reports Preclinical Data at ASH Annual Meeting in Diffuse Large B-Cell Lymphoma and T-Cell Acute Lymphoblastic Leukemia Suggesting Broad Potential of IPI-145 in Blood Cancers
Infinity Reports Preclinical Data at ASH Annual Meeting in Diffuse Large B-Cell Lymphoma and T-Cell Acute Lymphoblastic Leukemia Suggesting Broad Potential of IPI-145 in Blood Cancers
Yahoo/BusinessWire
large B-cell lymphoma
lymphoma
leukemia
T-cell acute lymphoblastic leukemia
IPI-145
Infinity Pharmaceuticals
Flag link:
Seattle Genetics highlights ADCETRIS data at lymphoma conference
Seattle Genetics highlights ADCETRIS data at lymphoma conference
Yahoo/Fly on the Wall
Seattle Genetics
Adcetris
lymphoma
Flag link:
Celgene's Revlimid wins additional FDA lymphoma approval
Celgene's Revlimid wins additional FDA lymphoma approval
Reuters
Celgene
Revlimid
FDA
lymphoma
mantle cell lymphoma
Flag link:
Eli Lilly's lymphoma drug fails in late-stage trial
Eli Lilly's lymphoma drug fails in late-stage trial
Reuters
lymphoma
enzastaurin
Eli Lilly
Flag link:
Isis Pharma, AstraZeneca Ink Deal
Isis Pharma, AstraZeneca Ink Deal
Yahoo/Zacks
Isis Pharmaceuticals
AstraZeneca
ISIS-STAT3Rx
lymphoma
Flag link:
Pharmacyclics slumps on disappointing study data
Pharmacyclics slumps on disappointing study data
Yahoo/AP
Pharmacyclics
ibrutinib
JNJ
lymphoma
leukemia
Flag link:

Pages